☆Palo Alto Investors LP
Quality Q
0.631
AUM ($M)
724
Positions
52
Turnover
0.11
Top-10 wt
61%
Herfindahl
0.049
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 56 positions · portfolio value $724M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆PTCT funds › | PTC THERAPEUTICS INC | TRIM | — | 10.4% | +0.8% | 75.0 | 918,846 | -2,761 | 5 | — |
| ☆ACHC funds › | ACADIA PHARMACEUTICALS INC | NEW | — | 10.0% | +10.0% | 72.5 | 2,864,096 | +2,864,096 | 1 | — |
| ☆INSM funds › | INSMED INC | TRIM | — | 6.1% | -4.3% | 44.1 | 413,980 | -1,289 | 5 | — |
| ☆CUSIP:604749AB7 funds › | MIRUM PHARMACEUTICALS INC | NEW | — | 5.6% | +5.6% | 40.8 | 348,808 | +348,808 | 1 | — |
| ☆ANAB funds › | ANAPTYSBIO INC | TRIM | — | 5.6% | +0.2% | 40.7 | 603,489 | -34,672 | 5 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | TRIM | — | 5.4% | -0.5% | 39.1 | 682,777 | -2,405 | 5 | — |
| ☆DYN funds › | DYNE THERAPEUTICS INC | TRIM | — | 5.1% | +0.5% | 36.6 | 1,647,521 | -5,451 | 5 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP | TRIM | — | 4.7% | -1.0% | 33.9 | 62,587 | -222 | 5 | — |
| ☆IRON funds › | DISC MEDICINE INC | ADD | — | 4.2% | +0.3% | 30.5 | 416,646 | +14,927 | 5 | — |
| ☆BIIB funds › | BIOGEN INC | TRIM | — | 4.2% | +0.2% | 30.3 | 140,279 | -440 | 5 | — |
| ☆IOVA funds › | IOVANCE BIOTHERAPEUTICS INC | TRIM | — | 3.0% | -0.4% | 22.0 | 5,296,209 | -1,053,354 | 5 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | HOLD | — | 2.8% | +0.8% | 19.9 | 596,495 | +0 | 5 | — |
| ☆NVCR funds › | NOVOCURE LTD | HOLD | — | 2.7% | +0.5% | 19.4 | 1,280,439 | +0 | 5 | — |
| ☆SNDX funds › | SYNDAX PHARMACEUTICALS INC | HOLD | — | 2.6% | -0.5% | 18.9 | 864,986 | +0 | 5 | — |
| ☆ANNX funds › | ANNEXON INC | HOLD | — | 2.3% | -0.2% | 16.8 | 2,948,090 | +0 | 3 | — |
| ☆BCAX funds › | BICARA THERAPEUTICS INC | HOLD | — | 2.3% | +0.6% | 16.3 | 550,408 | +0 | 3 | — |
| ☆CDNA funds › | CAREDX INC | HOLD | — | 2.1% | +0.7% | 15.2 | 531,870 | +0 | 4 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC | ADD | — | 2.1% | +0.6% | 14.9 | 399,856 | +103,448 | 2 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | ADD | — | 1.8% | +0.5% | 12.8 | 5,831,813 | +4,317,309 | 3 | — |
| ☆ALKS funds › | ALKERMES PLC | HOLD | — | 1.8% | +0.4% | 12.7 | 242,560 | +0 | 5 | — |
| ☆TRAX funds › | FIRST TRACKS BIOTHERAPEUTICS | NEW | — | 1.7% | +1.7% | 12.1 | 603,489 | +603,489 | 1 | — |
| ☆PRTA funds › | PROTHENA CORP PLC | TRIM | — | 1.5% | -0.3% | 11.2 | 1,143,155 | -65,413 | 5 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | TRIM | — | 1.3% | +0.3% | 9.5 | 167,525 | -62,928 | 5 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | HOLD | — | 1.3% | +0.4% | 9.5 | 1,391,382 | +0 | 5 | — |
| ☆ACRS funds › | ACLARIS THERAPEUTICS INC | HOLD | — | 1.2% | +0.3% | 8.5 | 1,613,430 | +0 | 5 | — |
| ☆AGIO funds › | AGIOS PHARMACEUTICALS INC | HOLD | — | 1.1% | -0.0% | 7.9 | 213,601 | +0 | 5 | — |
| ☆CAPR funds › | CAPRICOR THERAPEUTICS INC | HOLD | — | 0.8% | -0.3% | 5.5 | 229,763 | +0 | 3 | — |
| ☆ALGN funds › | ALIGN TECHNOLOGY INC | TRIM | — | 0.7% | -0.4% | 5.3 | 31,389 | -10,131 | 5 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC - Restricted | TRIM | — | 0.4% | -0.0% | 3.2 | 33,546 | -26,439 | 4 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 0.4% | -0.0% | 3.1 | 51,345 | +0 | 3 | — |
| ☆NBIX funds › | NEUROCRINE BIOSCIENCES INC | HOLD | — | 0.4% | +0.1% | 3.1 | 18,117 | +0 | 5 | — |
| ☆EW funds › | EDWARDS LIFESCIENCES CORP | HOLD | — | 0.4% | +0.0% | 3.0 | 33,640 | +0 | 5 | — |
| ☆STOK funds › | STOKE THERAPEUTICS INC | HOLD | — | 0.4% | -0.0% | 2.8 | 84,631 | +0 | 5 | — |
| ☆CYTK funds › | CYTOKINETICS INC | HOLD | — | 0.4% | +0.1% | 2.7 | 32,195 | +0 | 2 | — |
| ☆PYXS funds › | PYXIS ONCOLOGY INC | TRIM | — | 0.4% | +0.1% | 2.6 | 864,277 | -146,233 | 5 | — |
| ☆EHTH funds › | EHEALTH INC | HOLD | — | 0.3% | +0.0% | 2.2 | 1,482,797 | +0 | 5 | — |
| ☆CRSP funds › | CRISPR THERAPEUTICS AG | HOLD | — | 0.3% | +0.0% | 2.2 | 39,605 | +0 | 5 | — |
| ☆SGMT funds › | SAGIMET BIOSCIENCES INC-A | NEW | — | 0.3% | +0.3% | 1.9 | 250,000 | +250,000 | 1 | — |
| ☆NUVB funds › | NUVATION BIO INC | TRIM | — | 0.3% | -0.1% | 1.9 | 326,609 | -182,237 | 5 | — |
| ☆BNTX funds › | BIONTECH SE-ADR | HOLD | — | 0.3% | -0.0% | 1.8 | 19,614 | +0 | 5 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC ADR | HOLD | — | 0.2% | +0.1% | 1.6 | 115,616 | +0 | 3 | — |
| ☆HUM funds › | HUMANA INC | HOLD | — | 0.2% | +0.1% | 1.6 | 3,985 | +0 | 5 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA CO NV | NEW | — | 0.2% | +0.2% | 1.5 | 44,359 | +44,359 | 1 | — |
| ☆VSTM funds › | VERASTEM INC | ADD | — | 0.2% | -0.0% | 1.2 | 309,685 | +63,592 | 2 | — |
| ☆MDGL funds › | MADRIGAL PHARMACEUTICALS INC | HOLD | — | 0.1% | -0.0% | 1.0 | 1,787 | +0 | 2 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | HOLD | — | 0.1% | +0.1% | 0.9 | 24,500 | +0 | 5 | — |
| ☆BCYC funds › | BICYCLE THERAPEUTICS PLC-ADR | HOLD | — | 0.1% | -0.0% | 0.9 | 201,890 | +0 | 5 | — |
| ☆XERS funds › | XERIS BIOPHARMA HOLDINGS INC | HOLD | — | 0.1% | +0.0% | 0.8 | 104,410 | +0 | 2 | — |
| ☆ABEO funds › | ABEONA THERAPEUTICS INC | HOLD | — | 0.1% | +0.0% | 0.7 | 108,865 | +0 | 5 | — |
| ☆INSP funds › | INSPIRE MEDICAL SYSTEMS INC | HOLD | — | 0.1% | -0.0% | 0.4 | 8,772 | +0 | 3 | — |
| ☆PRQR funds › | PROQR THERAPEUTICS NV | HOLD | — | 0.0% | +0.0% | 0.4 | 188,807 | +0 | 4 | — |
| ☆ALDX funds › | ALDEYRA THERAPEUTICS INC | HOLD | — | 0.0% | +0.0% | 0.3 | 155,709 | +0 | 5 | — |
| ☆CUSIP:03152W109 funds › | AMICUS THERAPEUTICS INC | EXIT | — | 0.0% | -2.5% | 0.0 | 0 | -1,113,045 | 0 | — |
| ☆ACAD funds › | ACADIA PHARMACEUTICALS INC | EXIT | — | 0.0% | -9.8% | 0.0 | 0 | -2,872,695 | 0 | — |
| ☆DNLI funds › | DENALI THERAPEUTICS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -234,582 | 0 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.6% | 0.0 | 0 | -325,175 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 724 | 52 | 0.26 | 61% | 0.049 | 0.333 | — | in |
| 2026Q1 | 654 | 51 | 0.15 | 64% | 0.053 | 0.572 | — | in |
| 2025Q4 | 718 | 49 | 0.14 | 68% | 0.060 | 0.605 | — | in |
| 2025Q3 | 540 | 44 | 0.20 | 67% | 0.062 | 0.437 | — | in |
| 2025Q2 | 470 | 45 | 0.17 | 75% | 0.079 | 0.599 | — | entered |
| 2025Q1 | 525 | 44 | 0.00 | 75% | 0.076 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status